Harton is a biotechnology company pioneering the next revolution in patient-focused healthcare. We design and deliver novel personalized immune therapies to treat each and every patient. We connect target discovery and multiplex manufacturing technologies via AI, enabling us to accelerate design at an unlimited scale. We leverage next-gen sequencing, single-cell, and spatial biology to deliver personalized immune therapies to improve patient outcomes.
- Richard Terry CEO & CTO
- Evan Daugharthy President & CSO
- Jason Abelowitz SVP, Finance